BenzingaSeptember 8, 2026 at 6:16 AM NYLast Month
Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27
Freedom Capital Markets analyst Gene Mannheimer downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $24 to $27.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
